Subtopic Deep Dive
Self-Expanding Metal Stents for Gastric Outlet Obstruction
Research Guide
What is Self-Expanding Metal Stents for Gastric Outlet Obstruction?
Self-expanding metal stents (SEMS) are endoscopic devices deployed to palliate malignant gastric outlet obstruction (GOO) by restoring luminal patency in patients with pancreatic or gastric cancers.
SEMS provide rapid symptom relief compared to surgical gastrojejunostomy, with shorter hospital stays but risks of migration and occlusion (Nagaraja et al., 2014, 111 citations). Recent studies compare SEMS to EUS-guided gastroenterostomy using lumen-apposing metal stents for improved durability (Tyberg et al., 2016, 248 citations; Khashab et al., 2017, 232 citations). Over 20 papers since 2011 assess clinical success, stent dysfunction, and nutritional outcomes.
Why It Matters
SEMS enable quicker oral intake resumption and reduced hospital stays in inoperable malignant GOO patients, improving quality of life (Upchurch et al., 2018, 92 citations). Nagaraja et al. (2014) meta-analysis shows superior short-term outcomes versus surgery, guiding palliative care in pancreatic cancer. Tyberg et al. (2016) and Khashab et al. (2017) demonstrate EUS-guided alternatives reduce tumor ingrowth, influencing ESGE guidelines (Van der Merwe et al., 2021, 416 citations).
Key Research Challenges
Stent Migration Risk
Migration occurs in 10-20% of SEMS placements, leading to recurrent obstruction (Upchurch et al., 2018). Covered versus uncovered stents show varying rates in randomized trials (Maetani et al., 2013, 60 citations). Technical factors like tumor location exacerbate this issue.
Tumor Ingrowth Occlusion
Uncovered SEMS face ingrowth risks shortening patency to 2-4 months (Nagaraja et al., 2014). Triple-layered covered stents aim to prevent this but increase migration (Maetani et al., 2013). Long-term durability remains limited versus EUS-GE (Kerdsirichairat et al., 2019, 105 citations).
Surgical vs Endoscopic Comparison
Meta-analyses favor stenting short-term but note higher reintervention rates long-term (Nagaraja et al., 2014; Upchurch et al., 2018). Multicenter trials compare EUS-GE to surgery for success rates (Khashab et al., 2017). Cost-effectiveness varies by patient survival (Roy et al., 2012).
Essential Papers
Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Van der Merwe, Roy L.J. van Wanrooij, Michiel Bronswijk et al. · 2021 · Endoscopy · 416 citations
Main Recommendations 1 ESGE recommends the use of endoscopic ultrasound-guided biliary drainage (EUS-BD) over percutaneous transhepatic biliary drainage (PTBD) after failed endoscopic retrograde ch...
Endoscopic ultrasound-guided gastrojejunostomy with a lumen-apposing metal stent: a multicenter, international experience
Amy Tyberg, Manuel Pérez‐Miranda, Ramón Sánchez-Ocaña et al. · 2016 · Endoscopy International Open · 248 citations
\nBackground: Surgical gastrojejunostomy and enteral self-expanding metal stents are efficacious for the management of gastric outlet obstruction but limited by high complication rates and short-te...
International multicenter comparative trial of endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for the treatment of malignant gastric outlet obstruction
Mouen A. Khashab, Majidah Bukhari, Todd H. Baron et al. · 2017 · Endoscopy International Open · 232 citations
Abstract Background and study aims EUS-guided gastroenterostomy (EUS-GE) is a novel procedure that potentially offers long-lasting luminal patency without the risk of tumor ingrowth/overgrowth. Thi...
Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review
Roy L.J. van Wanrooij, Michiel Bronswijk, Rastislav Kunda et al. · 2022 · Endoscopy · 154 citations
Main Recommendations 1 ESGE recommends a prolonged course of a prophylactic broad-spectrum antibiotic in patients with ascites who are undergoing therapeutic endoscopic ultrasound (EUS) procedures....
Technical review of endoscopic ultrasonography‐guided gastroenterostomy in 2017
Takao Itoi, Todd H. Baron, Mouen A. Khashab et al. · 2016 · Digestive Endoscopy · 129 citations
Gastric outlet obstruction ( GOO ) can be caused by benign and malignant diseases and often leads to a reduction in patient quality of life. Lately, endoscopic ultrasonography ( EUS )‐guided gastro...
Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials.
Vinayak Nagaraja, Guy D. Eslick, Michael R. Cox · 2014 · PubMed · 111 citations
These findings suggest that stent placement is associated with better short-term outcomes and hence, duodenal stenting is a safe means of palliating malignant gastric outflow obstruction. However, ...
The role of endoscopy in gastroduodenal obstruction and gastroparesis
Norio Fukami, Michelle A. Anderson, Karim Khan et al. · 2011 · Gastrointestinal Endoscopy · 108 citations
Reading Guide
Foundational Papers
Start with Nagaraja et al. (2014, 111 citations) for SEMS vs surgery meta-analysis establishing short-term superiority; Fukami et al. (2011, 108 citations) for endoscopic role overview.
Recent Advances
Study Khashab et al. (2017, 232 citations) multicenter EUS-GE trial and Kerdsirichairat et al. (2019, 105 citations) for durability data; Van der Merwe et al. (2021, 416 citations) ESGE guideline.
Core Methods
Enteral SEMS deployment via duodenoscopy; EUS-guided gastroenterostomy with lumen-apposing stents; meta-regression for patency comparisons (Tyberg et al., 2016; Itoi et al., 2016).
How PapersFlow Helps You Research Self-Expanding Metal Stents for Gastric Outlet Obstruction
Discover & Search
Research Agent uses searchPapers and citationGraph to map SEMS literature from Nagaraja et al. (2014, 111 citations) to ESGE guidelines (Van der Merwe et al., 2021), revealing EUS-GE evolution; exaSearch uncovers 50+ GOO trials, while findSimilarPapers links Tyberg et al. (2016) to multicenter comparatives.
Analyze & Verify
Analysis Agent applies readPaperContent to extract patency rates from Khashab et al. (2017), verifies meta-analysis claims via verifyResponse (CoVe) against Nagaraja (2014), and runs PythonAnalysis for GRADE grading of evidence levels in RCTs like Maetani et al. (2013); statistical verification compares stent vs surgery outcomes using pandas survival curves.
Synthesize & Write
Synthesis Agent detects gaps in long-term SEMS durability versus EUS-GE (Kerdsirichairat et al., 2019), flags contradictions in migration data; Writing Agent uses latexEditText, latexSyncCitations for review drafts, latexCompile for figures, and exportMermaid for treatment pathway diagrams.
Use Cases
"Compare stent migration rates in malignant GOO meta-analyses"
Research Agent → searchPapers('SEMS migration GOO') → Analysis Agent → runPythonAnalysis(pandas meta-regression on rates from Nagaraja 2014, Upchurch 2018) → outputs GRADE-scored forest plot CSV.
"Draft LaTeX review on EUS-GE vs SEMS for GOO palliation"
Synthesis Agent → gap detection (Tyberg 2016 vs Khashab 2017) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(all listed papers) → latexCompile → outputs compiled PDF with bibliography.
"Find code for GOO stent patency survival analysis"
Research Agent → paperExtractUrls(recent GOO papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs R/Python scripts for Kaplan-Meier curves from Kerdsirichairat 2019 dataset simulations.
Automated Workflows
Deep Research workflow scans 50+ GOO papers via citationGraph from foundational Nagaraja (2014), generating structured systematic review with GRADE tables. DeepScan applies 7-step CoVe to verify EUS-GE superiority claims in Tyberg (2016) versus surgery. Theorizer synthesizes stent dysfunction mechanisms into predictive models from meta-analyses.
Frequently Asked Questions
What defines self-expanding metal stents for GOO?
SEMS are wire-mesh stents deployed endoscopically to bypass malignant GOO from pancreatic/gastric cancers, restoring gastric emptying (Fukami et al., 2011).
What methods compare SEMS to alternatives?
Meta-analyses and RCTs compare SEMS clinical success, patency, and costs to surgical gastrojejunostomy and EUS-GE (Nagaraja et al., 2014; Khashab et al., 2017).
What are key papers on SEMS for GOO?
Nagaraja et al. (2014, 111 citations) meta-analysis favors short-term stenting; Tyberg et al. (2016, 248 citations) introduces EUS-GE; Van der Merwe et al. (2021, 416 citations) ESGE guideline.
What open problems exist in GOO stenting?
Long-term patency beyond 6 months, optimal covered vs uncovered designs, and head-to-head RCTs with EUS-GE remain unresolved (Kerdsirichairat et al., 2019; Upchurch et al., 2018).
Research Esophageal and GI Pathology with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Self-Expanding Metal Stents for Gastric Outlet Obstruction with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Esophageal and GI Pathology Research Guide